Categories: BrainHealthcareNews

Connecticut Innovations Invests $11.3 Million in Early-Stage Companies in Q1 FY26

Deals leveraged $86.9 million in outside capital in the first quarter of the fiscal year

NEW HAVEN, Conn., Nov. 3, 2025 /PRNewswire/ — Connecticut Innovations (CI), Connecticut’s strategic venture capital arm, today announced that it invested approximately $11.3 million in 25 companies and venture funds during the first quarter of its fiscal year, ending September 30, 2025. CI’s investments leveraged $86.9 million in outside capital and generated $7.0 million in proceeds during the quarter.

CI invested approximately $1.5 million in climate tech companies over the quarter, and another $2.2 million in venture funds. More than half of the quarter’s investment dollars, $6.9 million, were invested in the healthcare sector. The remaining investments were in consumer and technology companies.

“With the launch of our new $50 million AI/Q Fund, CI is doubling down on the technologies shaping the future,” said Matt Storeygard, senior managing director of investments. “Bexorg, one of our largest healthcare investments this quarter and a new addition to the AI/Q Fund, shows how AI can drive real-world change in biosciences by combining artificial intelligence with a whole-human brain perfusion platform to accelerate breakthroughs in brain health.”

“CI began the new fiscal year with steady deal activity and strong participation across key sectors like healthcare, climate tech and AI,” said Peter Longo, senior managing director of investments. “It’s a promising start to the year and reflects the continued demand for capital among Connecticut’s growing companies.”

About Connecticut Innovations

Connecticut Innovations (CI) is Connecticut’s strategic venture capital arm and is the leading source of financing and ongoing support for innovative, growing companies. By offering equity and debt investments, strategic guidance and introductions to valuable partners, we help promising businesses thrive. For more information, please visit http://www.ctinnovations.com.

Media Contact
Lauren Carmody
Connecticut Innovations
860.258.7829
Lauren.Carmody@ctinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/connecticut-innovations-invests-11-3-million-in-early-stage-companies-in-q1-fy26–302601407.html

SOURCE Connecticut Innovations

Staff

Recent Posts

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…

2 hours ago

Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations

While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn…

2 hours ago

Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources

DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and…

2 hours ago

A Christmas Message to the DEA’s Diversion Anti Marijuana Cabal

This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally…

5 hours ago

Kanazawa University research: High-speed AFM imaging reveals how brain enzyme forms dodecameric ring structure

KANAZAWA, Japan, Dec. 26, 2025 /PRNewswire/ -- Scientists at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa…

11 hours ago

Arspura Showcases a New Standard for Healthy Kitchen Living at CES 2026

LOS ANGELES, Dec. 25, 2025 /PRNewswire/ -- From January 6–9, 2026, visitors can experience Arspura's…

17 hours ago